Portola Pharmaceuticals, Inc.
Part of Alexion Pharmaceuticals Inc.
- UEI
- FH2MKRASLYM3
- CAGE
- 5XNN2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Boston, MA
DKCXLGANZAN3
-
Parent
Boston, MA
DKCXLGANZAN3
- SAM.gov registration date
- Website
- alexion.com
- Founded
- 1992
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| SYK blockade in bullous skin diseases | National Institutes of Health | $297,575 | |
| Prolonged and severe thrombocytopenia in neonates | National Institutes of Health | -$422,650 |
Quick answers
Is Portola Pharmaceuticals, Inc. registered in SAM.gov?
Portola Pharmaceuticals, Inc.'s SAM.gov registration expired on November 17, 2022.
Which contract vehicles does Portola Pharmaceuticals, Inc. hold?
Portola Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Portola Pharmaceuticals, Inc.'s most recent federal award?
Portola Pharmaceuticals, Inc.'s most recent federal grant award is SYK blockade in bullous skin diseases (R43AR063129), from National Institutes of Health, on September 1, 2012.
On GovTribe
See Portola Pharmaceuticals, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors